List of Tables
Table 1. Global Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chidamide
Table 3. Key Players of Selinexor
Table 4. Key Players of Other
Table 5. Global Peripheral T-cell lymphoma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Peripheral T-cell lymphoma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Peripheral T-cell lymphoma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Peripheral T-cell lymphoma Therapy Market Share by Region (2020-2025)
Table 9. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Peripheral T-cell lymphoma Therapy Market Share by Region (2026-2031)
Table 11. Peripheral T-cell lymphoma Therapy Market Trends
Table 12. Peripheral T-cell lymphoma Therapy Market Drivers
Table 13. Peripheral T-cell lymphoma Therapy Market Challenges
Table 14. Peripheral T-cell lymphoma Therapy Market Restraints
Table 15. Global Peripheral T-cell lymphoma Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Peripheral T-cell lymphoma Therapy Market Share by Players (2020-2025)
Table 17. Global Top Peripheral T-cell lymphoma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral T-cell lymphoma Therapy as of 2024)
Table 18. Ranking of Global Top Peripheral T-cell lymphoma Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Peripheral T-cell lymphoma Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Peripheral T-cell lymphoma Therapy, Headquarters and Area Served
Table 21. Global Key Players of Peripheral T-cell lymphoma Therapy, Product and Application
Table 22. Global Key Players of Peripheral T-cell lymphoma Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Peripheral T-cell lymphoma Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Peripheral T-cell lymphoma Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Peripheral T-cell lymphoma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Peripheral T-cell lymphoma Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Peripheral T-cell lymphoma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Peripheral T-cell lymphoma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Peripheral T-cell lymphoma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Peripheral T-cell lymphoma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Peripheral T-cell lymphoma Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Peripheral T-cell lymphoma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Antengene Company Details
Table 48. Antengene Business Overview
Table 49. Antengene Peripheral T-cell lymphoma Therapy Product
Table 50. Antengene Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 51. Antengene Recent Development
Table 52. Genor BioPharma Co., Ltd. Company Details
Table 53. Genor BioPharma Co., Ltd. Business Overview
Table 54. Genor BioPharma Co., Ltd. Peripheral T-cell lymphoma Therapy Product
Table 55. Genor BioPharma Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 56. Genor BioPharma Co., Ltd. Recent Development
Table 57. Hospira (Pfizer Inc.) Company Details
Table 58. Hospira (Pfizer Inc.) Business Overview
Table 59. Hospira (Pfizer Inc.) Peripheral T-cell lymphoma Therapy Product
Table 60. Hospira (Pfizer Inc.) Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 61. Hospira (Pfizer Inc.) Recent Development
Table 62. Dizal Pharma Company Details
Table 63. Dizal Pharma Business Overview
Table 64. Dizal Pharma Peripheral T-cell lymphoma Therapy Product
Table 65. Dizal Pharma Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 66. Dizal Pharma Recent Development
Table 67. Bristol-Myers Squibb Company Company Details
Table 68. Bristol-Myers Squibb Company Business Overview
Table 69. Bristol-Myers Squibb Company Peripheral T-cell lymphoma Therapy Product
Table 70. Bristol-Myers Squibb Company Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 71. Bristol-Myers Squibb Company Recent Development
Table 72. Sigma-Tau Pharmaceuticals, Inc. Company Details
Table 73. Sigma-Tau Pharmaceuticals, Inc. Business Overview
Table 74. Sigma-Tau Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 75. Sigma-Tau Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 76. Sigma-Tau Pharmaceuticals, Inc. Recent Development
Table 77. Pacira Pharmaceuticals, Inc. Company Details
Table 78. Pacira Pharmaceuticals, Inc. Business Overview
Table 79. Pacira Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 80. Pacira Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 81. Pacira Pharmaceuticals, Inc. Recent Development
Table 82. Spectrum Pharmaceuticals, Inc. Company Details
Table 83. Spectrum Pharmaceuticals, Inc. Business Overview
Table 84. Spectrum Pharmaceuticals, Inc. Peripheral T-cell lymphoma Therapy Product
Table 85. Spectrum Pharmaceuticals, Inc. Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 86. Spectrum Pharmaceuticals, Inc. Recent Development
Table 87. Celgene Corporation Company Details
Table 88. Celgene Corporation Business Overview
Table 89. Celgene Corporation Peripheral T-cell lymphoma Therapy Product
Table 90. Celgene Corporation Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 91. Celgene Corporation Recent Development
Table 92. Eisai Co., Ltd. Company Details
Table 93. Eisai Co., Ltd. Business Overview
Table 94. Eisai Co., Ltd. Peripheral T-cell lymphoma Therapy Product
Table 95. Eisai Co., Ltd. Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 96. Eisai Co., Ltd. Recent Development
Table 97. Leadiant Biosciences Company Details
Table 98. Leadiant Biosciences Business Overview
Table 99. Leadiant Biosciences Peripheral T-cell lymphoma Therapy Product
Table 100. Leadiant Biosciences Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 101. Leadiant Biosciences Recent Development
Table 102. Merck Company Details
Table 103. Merck Business Overview
Table 104. Merck Peripheral T-cell lymphoma Therapy Product
Table 105. Merck Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 106. Merck Recent Development
Table 107. Genmab AS Company Details
Table 108. Genmab AS Business Overview
Table 109. Genmab AS Peripheral T-cell lymphoma Therapy Product
Table 110. Genmab AS Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 111. Genmab AS Recent Development
Table 112. HUYABIO International Company Details
Table 113. HUYABIO International Business Overview
Table 114. HUYABIO International Peripheral T-cell lymphoma Therapy Product
Table 115. HUYABIO International Revenue in Peripheral T-cell lymphoma Therapy Business (2020-2025) & (US$ Million)
Table 116. HUYABIO International Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Peripheral T-cell lymphoma Therapy Picture
Figure 2. Global Peripheral T-cell lymphoma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Peripheral T-cell lymphoma Therapy Market Share by Type: 2024 VS 2031
Figure 4. Chidamide Features
Figure 5. Selinexor Features
Figure 6. Other Features
Figure 7. Global Peripheral T-cell lymphoma Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Peripheral T-cell lymphoma Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Peripheral T-cell lymphoma Therapy Report Years Considered
Figure 12. Global Peripheral T-cell lymphoma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Peripheral T-cell lymphoma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Peripheral T-cell lymphoma Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Peripheral T-cell lymphoma Therapy Market Share by Players in 2024
Figure 16. Global Top Peripheral T-cell lymphoma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral T-cell lymphoma Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Peripheral T-cell lymphoma Therapy Revenue in 2024
Figure 18. North America Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Peripheral T-cell lymphoma Therapy Market Share by Country (2020-2031)
Figure 20. United States Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Peripheral T-cell lymphoma Therapy Market Share by Country (2020-2031)
Figure 24. Germany Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Peripheral T-cell lymphoma Therapy Market Share by Region (2020-2031)
Figure 32. China Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Peripheral T-cell lymphoma Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Peripheral T-cell lymphoma Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Peripheral T-cell lymphoma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Antengene Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 48. Genor BioPharma Co., Ltd. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 49. Hospira (Pfizer Inc.) Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 50. Dizal Pharma Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 52. Sigma-Tau Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 53. Pacira Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 54. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 55. Celgene Corporation Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 56. Eisai Co., Ltd. Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 57. Leadiant Biosciences Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 58. Merck Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 59. Genmab AS Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 60. HUYABIO International Revenue Growth Rate in Peripheral T-cell lymphoma Therapy Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
